The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as the "Company") today announced the successful...
Hence then, the article about cardiovalve completes target study enrollment for ce registration study for tricuspid valve replacement was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement )
Also on site :
- Dolly Parton donated $1 million to Vanderbilt University Medical Center in 2020 to help fund the critical early research behind Moderna’s COVID-19 vaccine
- In 1984, Alabama Released the Wrong Song as a Single; Radio DJs Flipped the Record Over and Made the B-Side Their 14th Straight No. 1
- ‘Fastest entertainment property in history’: GTA VI arrives to test a thin November box office